Single User License
INR 168900
Site License
INR 337800
Corporate User License
INR 506700

Service Tax Additional

select a format
Price

Single User License
USD 2500
Site License
USD 5000
Corporate User License
USD 7500

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"

Ken Research completed the report successfully with tough deadline and large requirement. Really appreciate it... "Sales Manager, Largest India Aesthetic Laser Manufacturer"

We found the report really useful in understanding the complex Indian market and it provided lots of high quality insights. On the basis of this we commissioned Ken to produce a bespoke follow up to answer some specific questions about our market. This is now being used to help develop our marketing and sales strategy. We were very pleased with the comprehensive coverage, detail provided and actionable insights.... "Owner, Therefore Consulting UK"


Cancer Pain Global Clinical Trials Review, H1

Cancer Pain Global Clinical Trials Review, H1


  Request for Sample Report

Executive Summary

Cancer Pain Global Clinical Trials Review, H1, 2015

GlobalData's clinical trial report, "Cancer Pain Global Clinical Trials Review, H1, 2015" provides an overview of Cancer Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Cancer Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Cancer Pain 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Five Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Cancer Pain to Central Nervous System Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Cancer Pain to Central Nervous System Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Cancer Pain 25

Subjects Recruited Over a Period of Time 30

Clinical Trials by Sponsor Type 31

Prominent Sponsors 32

Top Companies Participating in Cancer Pain Therapeutics Clinical Trials 33

Prominent Drugs 34

Latest Clinical Trials News on Cancer Pain 35

May 04, 2015: Sorrento Announces Positive TRIBECA Registrational Study Results 35

Clinical Trial Profiles 36

Clinical Trial Overview of Top Companies 36

Johnson & Johnson 36

Clinical Trial Overview of Johnson & Johnson 36

Janssen Global Services, LLC 39

Clinical Trial Overview of Janssen Global Services, LLC 39

Mundipharma International Ltd 40

Clinical Trial Overview of Mundipharma International Ltd 40

Kirin Holdings Company, Limited 41

Clinical Trial Overview of Kirin Holdings Company, Limited 41

GW Pharmaceuticals Plc 42

Clinical Trial Overview of GW Pharmaceuticals Plc 42

Grunenthal GmbH 43

Clinical Trial Overview of Grunenthal GmbH 43

Takeda Pharmaceutical Company Limited 44

Clinical Trial Overview of Takeda Pharmaceutical Company Limited 44

Pfizer Inc. 45

Clinical Trial Overview of Pfizer Inc. 45

Otsuka Holdings Co., Ltd. 46

Clinical Trial Overview of Otsuka Holdings Co., Ltd. 46

Kyowa Hakko Kirin Co., Ltd. 47

Clinical Trial Overview of Kyowa Hakko Kirin Co., Ltd. 47

Clinical Trial Overview of Top Institutes / Government 48

Alberta Health Services 48

Clinical Trial Overview of Alberta Health Services 48

Erasmus MC 49

Clinical Trial Overview of Erasmus MC 49

Mario Negri Institute for Pharmacological Research 50

Clinical Trial Overview of Mario Negri Institute for Pharmacological Research 50

Mayo Clinic 51

Clinical Trial Overview of Mayo Clinic 51

Norwegian University of Science and Technology 52

Clinical Trial Overview of Norwegian University of Science and Technology 52

Assistance Publique-Hopitaux de Paris 53

Clinical Trial Overview of Assistance Publique-Hopitaux de Paris 53

Chinese University of Hong Kong 54

Clinical Trial Overview of Chinese University of Hong Kong 54

Chonbuk National University Hospital 55

Clinical Trial Overview of Chonbuk National University Hospital 55

Gloucestershire Hospitals NHS Trust 56

Clinical Trial Overview of Gloucestershire Hospitals NHS Trust 56

Indiana University 57

Clinical Trial Overview of Indiana University 57

Five Key Clinical Profiles 58

Appendix 87

Abbreviations 87

Definitions 87

Research Methodology 88

Secondary Research 88

About GlobalData 89

Contact Us 89

Disclaimer 89

Source 90

List of Figures

Cancer Pain Therapeutics, Global, Clinical Trials by Region (%), 2015* 7

Cancer Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Cancer Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Cancer Pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10

Cancer Pain Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11

Cancer Pain Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12

Cancer Pain Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015* 13

Cancer Pain Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14

Proportion of Cancer Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2015* 15

Cancer Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Cancer Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Cancer Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2015* 18

Cancer Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Cancer Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Cancer Pain Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21

Cancer Pain Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22

Cancer Pain Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Cancer Pain Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Cancer Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 30

Cancer Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 31

Cancer Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 32

Cancer Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 33

Cancer Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 34

GlobalData Methodology 88

List of Tables

Cancer Pain Therapeutics, Global, Clinical Trials by Region, 2015* 7

Cancer Pain Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8

Cancer Pain Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9

Cancer Pain Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10

Cancer Pain Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11

Cancer Pain Therapeutics Clinical Trials, North America, Top Countries, 2015* 12

Cancer Pain Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015* 13

Cancer Pain Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14

Proportion of Cancer Pain to Central Nervous System Clinical Trials, G7 Countries (%), 2015* 15

Cancer Pain Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16

Cancer Pain Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17

Proportion of Cancer Pain to Central Nervous System Clinical Trials, E7 Countries (%), 2015* 18

Cancer Pain Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19

Cancer Pain Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20

Cancer Pain Therapeutics, Global, Clinical Trials by Phase, 2015* 21

Cancer Pain Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22

Cancer Pain Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23

Cancer Pain Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24

Cancer Pain Therapeutics, Global, Suspended Clinical Trials, 2015* 25

Cancer Pain Therapeutics, Global, Withdrawn Clinical Trials, 2015* 26

Cancer Pain Therapeutics, Global, Terminated Clinical Trials, 2015* 27

Cancer Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 30

Cancer Pain Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 31

Cancer Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 32

Cancer Pain Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 33

Cancer Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 34

Cancer Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2015* 36

Cancer Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Global Services, LLC, 2015* 39

Cancer Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Mundipharma International Ltd, 2015* 40

Cancer Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Kirin Holdings Company, Limited, 2015* 41

Cancer Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by GW Pharmaceuticals Plc, 2015* 42

Cancer Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Grunenthal GmbH, 2015* 43

Cancer Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2015* 44

Cancer Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 45

Cancer Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2015* 46

Cancer Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyowa Hakko Kirin Co., Ltd., 2015* 47

Cancer Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Alberta Health Services, 2015* 48

Cancer Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2015* 49

Cancer Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Mario Negri Institute for Pharmacological Research, 2015* 50

Cancer Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015* 51

Cancer Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Norwegian University of Science and Technology, 2015* 52

Cancer Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique-Hopitaux de Paris, 2015* 53

Cancer Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2015* 54

Cancer Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Chonbuk National University Hospital, 2015* 55

Cancer Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Gloucestershire Hospitals NHS Trust, 2015* 56

Cancer Pain Therapeutics Clinical Trials Market, Global, Clinical Trials by Indiana University, 2015* 57

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Johnson & Johnson

Janssen Global Services, LLC

Mundipharma International Ltd

Kirin Holdings Company, Limited

GW Pharmaceuticals Plc

Grunenthal GmbH

Takeda Pharmaceutical Company Limited

Pfizer Inc.

Otsuka Holdings Co., Ltd.

Kyowa Hakko Kirin Co., Ltd.

Cancer Pain Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Cancer Pain, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania.


Related Products in vertical
Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com